FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989884456> ?p ?o ?g. }

• W2989884456 endingPage "459" @default.
• W2989884456 startingPage "447" @default.
• W2989884456 abstract "Abstract The aldehyde dehydrogenases (ALDH) are a major family of detoxifying enzymes that contribute to cancer progression and therapy resistance. ALDH overexpression is associated with a poor prognosis in many cancer types. The use of multi-ALDH isoform or isoform-specific ALDH inhibitors as anticancer agents is currently hindered by the lack of viable candidates. Most multi-ALDH isoform inhibitors lack bioavailability and are nonspecific or toxic, whereas most isoform-specific inhibitors are not effective as monotherapy due to the overlapping functions of ALDH family members. The present study details the development of a novel, potent, multi-isoform ALDH inhibitor, called KS100. The rationale for drug development was that inhibition of multiple ALDH isoforms might be more efficacious for cancer compared with isoform-specific inhibition. Enzymatic IC50s of KS100 were 207, 1,410, and 240 nmol/L toward ALDH1A1, 2, and 3A1, respectively. Toxicity of KS100 was mitigated by development of a nanoliposomal formulation, called NanoKS100. NanoKS100 had a loading efficiency of approximately 69% and was stable long-term. NanoKS100 was 5-fold more selective for killing melanoma cells compared with normal human fibroblasts. NanoKS100 administered intravenously at a submaximal dose (3-fold lower) was effective at inhibiting xenografted melanoma tumor growth by approximately 65% without organ-related toxicity. Mechanistically, inhibition by KS100 significantly reduced total cellular ALDH activity to increase reactive oxygen species generation, lipid peroxidation, and accumulation of toxic aldehydes leading to apoptosis and autophagy. Collectively, these data suggest the successful preclinical development of a nontoxic, bioavailable, nanoliposomal formulation containing a novel multi-ALDH isoform inhibitor effective in the treatment of cancer." @default.
• W2989884456 created "2019-12-05" @default.
• W2989884456 creator A5024284986 @default.
• W2989884456 creator A5030053365 @default.
• W2989884456 creator A5033490428 @default.
• W2989884456 creator A5048058203 @default.
• W2989884456 creator A5064767923 @default.
• W2989884456 creator A5073292112 @default.
• W2989884456 creator A5074801978 @default.
• W2989884456 creator A5086634091 @default.
• W2989884456 creator A5087789524 @default.
• W2989884456 date "2020-02-01" @default.
• W2989884456 modified "2023-10-10" @default.
• W2989884456 title "Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent" @default.
• W2989884456 cites W1037528781 @default.
• W2989884456 cites W1537399669 @default.
• W2989884456 cites W1844728007 @default.
• W2989884456 cites W1958877028 @default.
• W2989884456 cites W1963940785 @default.
• W2989884456 cites W1968332094 @default.
• W2989884456 cites W1979404419 @default.
• W2989884456 cites W1984457940 @default.
• W2989884456 cites W2014878118 @default.
• W2989884456 cites W2021952312 @default.
• W2989884456 cites W2036674484 @default.
• W2989884456 cites W2039124133 @default.
• W2989884456 cites W2050946558 @default.
• W2989884456 cites W2052902127 @default.
• W2989884456 cites W2054812913 @default.
• W2989884456 cites W2058569154 @default.
• W2989884456 cites W2068990310 @default.
• W2989884456 cites W2073315333 @default.
• W2989884456 cites W2079417712 @default.
• W2989884456 cites W2082088498 @default.
• W2989884456 cites W2082395080 @default.
• W2989884456 cites W2084251083 @default.
• W2989884456 cites W2085275390 @default.
• W2989884456 cites W2094332976 @default.
• W2989884456 cites W2111649022 @default.
• W2989884456 cites W2115540454 @default.
• W2989884456 cites W2122721237 @default.
• W2989884456 cites W2125898076 @default.
• W2989884456 cites W2128450196 @default.
• W2989884456 cites W2129852694 @default.
• W2989884456 cites W2144190812 @default.
• W2989884456 cites W2150479858 @default.
• W2989884456 cites W2155091769 @default.
• W2989884456 cites W2157005437 @default.
• W2989884456 cites W2160821308 @default.
• W2989884456 cites W2166662937 @default.
• W2989884456 cites W2236402171 @default.
• W2989884456 cites W2274600454 @default.
• W2989884456 cites W2322016289 @default.
• W2989884456 cites W2470459065 @default.
• W2989884456 cites W2471438863 @default.
• W2989884456 cites W2491982852 @default.
• W2989884456 cites W2508693260 @default.
• W2989884456 cites W2516839465 @default.
• W2989884456 cites W2562712860 @default.
• W2989884456 cites W2592541249 @default.
• W2989884456 cites W2598892417 @default.
• W2989884456 cites W2606784762 @default.
• W2989884456 cites W2622166199 @default.
• W2989884456 cites W2734324882 @default.
• W2989884456 cites W2742165567 @default.
• W2989884456 cites W2772332298 @default.
• W2989884456 cites W2782090199 @default.
• W2989884456 cites W2801706878 @default.
• W2989884456 cites W2804206597 @default.
• W2989884456 cites W2888555176 @default.
• W2989884456 cites W2890851843 @default.
• W2989884456 cites W2891484660 @default.
• W2989884456 cites W2892291303 @default.
• W2989884456 cites W2910769552 @default.
• W2989884456 cites W2972971655 @default.
• W2989884456 doi "https://doi.org/10.1158/1535-7163.mct-19-0360" @default.
• W2989884456 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31754071" @default.
• W2989884456 hasPublicationYear "2020" @default.
• W2989884456 type Work @default.
• W2989884456 sameAs 2989884456 @default.
• W2989884456 citedByCount "13" @default.
• W2989884456 countsByYear W29898844562020 @default.
• W2989884456 countsByYear W29898844562021 @default.
• W2989884456 countsByYear W29898844562022 @default.
• W2989884456 countsByYear W29898844562023 @default.
• W2989884456 crossrefType "journal-article" @default.
• W2989884456 hasAuthorship W2989884456A5024284986 @default.
• W2989884456 hasAuthorship W2989884456A5030053365 @default.
• W2989884456 hasAuthorship W2989884456A5033490428 @default.
• W2989884456 hasAuthorship W2989884456A5048058203 @default.
• W2989884456 hasAuthorship W2989884456A5064767923 @default.
• W2989884456 hasAuthorship W2989884456A5073292112 @default.
• W2989884456 hasAuthorship W2989884456A5074801978 @default.
• W2989884456 hasAuthorship W2989884456A5086634091 @default.
• W2989884456 hasAuthorship W2989884456A5087789524 @default.
• W2989884456 hasBestOaLocation W29898844561 @default.
• W2989884456 hasConcept C104317684 @default.
• W2989884456 hasConcept C121608353 @default.

• next